Le Lézard
Classified in: Transportation, Science and technology
Subject: CALENDAR OF EVENTS

Media Advisory: Bombardier to hold a press briefing


MONTRÉAL, QUÉBEC--(Marketwired - Nov. 16, 2017) - Bombardier (TSX:BBD.A)(TSX:BBD.B)(OTCQX:BDRBF) will hold a press briefing on the acceleration of Global 7000 aircraft interior completion operations and the inauguration of the Bombardier Centre of Excellence.

On this occasion, Alain Bellemare, President and Chief Executive Officer of Bombardier Inc., will be accompanied by Dominique Anglade, Deputy Premier, Minister of Economy, Science and Innovation and Minister responsible for Digital Strategy.

DATE: Friday, November 17, 2017
   
TIME: 10 AM EDT
   
LOCATION: Centre of Excellence
  2345 des Sources Boulevard 
  Pointe-Claire, Québec 
  H9P 2Z2

These press releases may also interest you

at 09:05
Aspen Technology Introduces New Strategic Planning for Sustainability Pathways Solution
Aspen Technology, Inc. , a global leader in industrial software, today introduced AspenTech Strategic Planning for Sustainability Pathwaystm ? a new and unique integrated modelling and optimization solution that aims to guide companies in carbon...

at 09:00
Known for Affordable Oral Health Care, Dental Care Acworth is Offering a New High-Tech AI Dental Patient Experience
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Introducing Ceph Squid: The Future of Storage Today, Reinforced by Strongest Alliance Yet
The Ceph Foundation, the global community dedicated to fostering the growth and advancement of Ceph, is excited to announce the release of Ceph Squid, which comes with several performance and space efficiency features along with enhanced protocol...

at 09:00
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
RapidScale Partners with Proficio to Offer SOC as a Service (SOCaaS) Delivering Advanced Threat Protection for Customers
RapidScale, a Cox Business company, bolsters its cybersecurity offerings with SOC as a Service that includes Managed Detection and Response (MDR), a cutting-edge security solution powered by Proficio. This strategic partnership reinforces...

at 09:00
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

More news about Science and technology...


News published on and distributed by: